Drug repurposing strategy to identify the putative leads against the Epidermal growth factor receptor (EGFR) from the USFDA-approved drug pool: Investigating the utility as an anticancer agent

View at publisher
Authors: Nemat Ali, Ali Mohammed Alaseem, M. Arockia Babu, Thakur Gurjeet Singh, Glowi A. Alasiri, Mohammad Fareed, Yogita Tyagi, Nisha Bansal
Cited by: 1
References: 31

Fields of Study & Subjects

Computational Drug Discovery Methods Cancer Hypoxia and Metabolism Metabolism Diabetes and Cancer

Publication details

Journal / source
Journal of Molecular Graphics and Modelling
Publisher
Elsevier BV
Volume
144
Pages
109310–109310
Publication date
31 January 2026
Language
EN